Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation

Background: The NRG1/ErbB4 signaling mechanism has been widely studied in the central nervous system for many years. However, the role of this pathway in modulating the intrinsic cardiac nervous system is largely unknown.Objective: The present study investigated whether the NRG1/ErbB4 signaling syst...

Full description

Bibliographic Details
Main Authors: Xiaoya Zhou, Zhuo Wang, Bing Huang, Shenxu Yuan, Xia Sheng, Lilei Yu, Guannan Meng, Yuhong Wang, Sunny S. Po, Hong Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2018.01082/full
_version_ 1819155248421273600
author Xiaoya Zhou
Zhuo Wang
Bing Huang
Shenxu Yuan
Xia Sheng
Lilei Yu
Guannan Meng
Yuhong Wang
Sunny S. Po
Hong Jiang
author_facet Xiaoya Zhou
Zhuo Wang
Bing Huang
Shenxu Yuan
Xia Sheng
Lilei Yu
Guannan Meng
Yuhong Wang
Sunny S. Po
Hong Jiang
author_sort Xiaoya Zhou
collection DOAJ
description Background: The NRG1/ErbB4 signaling mechanism has been widely studied in the central nervous system for many years. However, the role of this pathway in modulating the intrinsic cardiac nervous system is largely unknown.Objective: The present study investigated whether the NRG1/ErbB4 signaling system affects the activity of major atrial ganglionated plexi (GP) in a paroxysmal atrial fibrillation (AF) model by 6-h rapid atrial pacing (RAP).Methods: Twenty-four dogs were randomly divided into (1) a control group (saline microinjections into GP), (2) RAP group (saline microinjections into GP plus 6 h-RAP), (3) NRG1 group (microinjections of neuregulin-1 into GP plus 6 h-RAP) and (4) NRG1 + ERA group (microinjections of neuregulin-1 and ErbB4 receptor antagonist-ERA into GP plus 6 h-RAP). The effective refractory period (ERP), window of vulnerability (WOV), anterior right GP (ARGP) function and neural activity were measured. ARGP tissues were excised for histological study and western blotting.Results: When compared to the control group, 6 h-RAP produced a significant (1) decrease in ERP, an increase in ΣWOV, (2) an increase in ARGP neural activity and neural function, and (3) an increase in c-fos and nerve growth factor protein expression in the ARGP. However, microinjection of NRG1 into the ARGP prior to RAP prevented ERP shortening and AGRP activity enhancement and inhibited the expression of c-Fos and NGF proteins. Furthermore, these changes were significantly attenuated by pretreatment with an ErbB4 receptor antagonist.Conclusion: The NRG1/ErbB4 signaling pathway may exist in the GP, and activation of this pathway suppressed RAP-induced GP activation, atrial electrical remodeling and AF.
first_indexed 2024-12-22T15:33:57Z
format Article
id doaj.art-848d50db45ec4c77b7841c59fe9c8adb
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-22T15:33:57Z
publishDate 2018-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-848d50db45ec4c77b7841c59fe9c8adb2022-12-21T18:21:18ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-08-01910.3389/fphys.2018.01082376833Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial FibrillationXiaoya Zhou0Zhuo Wang1Bing Huang2Shenxu Yuan3Xia Sheng4Lilei Yu5Guannan Meng6Yuhong Wang7Sunny S. Po8Hong Jiang9Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaSir Run Run Shaw Institution of Clinical Medicine and Department of Cardiology, Sir Run Run Shaw Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaHeart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United StatesDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaBackground: The NRG1/ErbB4 signaling mechanism has been widely studied in the central nervous system for many years. However, the role of this pathway in modulating the intrinsic cardiac nervous system is largely unknown.Objective: The present study investigated whether the NRG1/ErbB4 signaling system affects the activity of major atrial ganglionated plexi (GP) in a paroxysmal atrial fibrillation (AF) model by 6-h rapid atrial pacing (RAP).Methods: Twenty-four dogs were randomly divided into (1) a control group (saline microinjections into GP), (2) RAP group (saline microinjections into GP plus 6 h-RAP), (3) NRG1 group (microinjections of neuregulin-1 into GP plus 6 h-RAP) and (4) NRG1 + ERA group (microinjections of neuregulin-1 and ErbB4 receptor antagonist-ERA into GP plus 6 h-RAP). The effective refractory period (ERP), window of vulnerability (WOV), anterior right GP (ARGP) function and neural activity were measured. ARGP tissues were excised for histological study and western blotting.Results: When compared to the control group, 6 h-RAP produced a significant (1) decrease in ERP, an increase in ΣWOV, (2) an increase in ARGP neural activity and neural function, and (3) an increase in c-fos and nerve growth factor protein expression in the ARGP. However, microinjection of NRG1 into the ARGP prior to RAP prevented ERP shortening and AGRP activity enhancement and inhibited the expression of c-Fos and NGF proteins. Furthermore, these changes were significantly attenuated by pretreatment with an ErbB4 receptor antagonist.Conclusion: The NRG1/ErbB4 signaling pathway may exist in the GP, and activation of this pathway suppressed RAP-induced GP activation, atrial electrical remodeling and AF.https://www.frontiersin.org/article/10.3389/fphys.2018.01082/fullneuregulin-1ErbB4atrial fibrillationautonomic nervous systemganglionated plexi
spellingShingle Xiaoya Zhou
Zhuo Wang
Bing Huang
Shenxu Yuan
Xia Sheng
Lilei Yu
Guannan Meng
Yuhong Wang
Sunny S. Po
Hong Jiang
Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation
Frontiers in Physiology
neuregulin-1
ErbB4
atrial fibrillation
autonomic nervous system
ganglionated plexi
title Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation
title_full Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation
title_fullStr Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation
title_full_unstemmed Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation
title_short Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System Is a Potential Treatment for Atrial Fibrillation
title_sort regulation of the nrg1 erbb4 pathway in the intrinsic cardiac nervous system is a potential treatment for atrial fibrillation
topic neuregulin-1
ErbB4
atrial fibrillation
autonomic nervous system
ganglionated plexi
url https://www.frontiersin.org/article/10.3389/fphys.2018.01082/full
work_keys_str_mv AT xiaoyazhou regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT zhuowang regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT binghuang regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT shenxuyuan regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT xiasheng regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT lileiyu regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT guannanmeng regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT yuhongwang regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT sunnyspo regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation
AT hongjiang regulationofthenrg1erbb4pathwayintheintrinsiccardiacnervoussystemisapotentialtreatmentforatrialfibrillation